-+ 0.00%
-+ 0.00%
-+ 0.00%

CERUS- MET PRIMARY EFFICACY ENDPOINT DEMONSTRATING NON-INFERIORITY OF INTERCEPT RBCS TO CONVENTIONAL RBCS BY ADJUSTED HEMOGLOBIN INCREMENT

路透·11/02/2026 21:00:00

请登录查看新闻详情